2025
05-07
NOVEMBER 2025
We are proud to announce that Erika Reategui, VP of Operations and Compliance at QACV Consulting, presented at the RQA 2025 International QA Conference in Belfast, Northern Ireland. The event gathered global quality professionals addressing the most pressing challenges in regulatory science and quality assurance.
Presentation Title: “One World, One Quality: Streamlining Sustainable QA Across Borders”
Erika’s session explored the evolving role of Quality Assurance in the face of Environmental, Social, and Governance (ESG) pressures, and the rapid globalization of clinical trials. As trial sponsors and regulators increasingly emphasize sustainability and harmonization, her talk provided practical insights on:
Drawing from QACV Consulting’s cross-border audit expertise, Erika shared tools and strategies for harmonizing global QA processes while maintaining data integrity and compliance.
Attendees left with actionable ideas to reduce redundancy, increase operational efficiency, and align quality practices with global ESG expectations.
We appreciate all participants that attended Erika’s presentation for been part of the conversation on building a unified, future-ready QA ecosystem.
Contact us to receive a copy of her presentation.
19-21
OCTOBER 2025
We had the incredible opportunity to attend the 22nd DIA Japan at the iconic Tokyo Big Sight in Ariake, Koto-ku.
QACV Consulting made a meaningful impact in Asia as we engaged in dynamic conversations around cross-border compliance, regulatory strategies, digital health innovation, and patient safety across the Asia-Pacific region.
As proud participants in the 22nd DIA Japan Annual Meeting, we connected with global and regional stakeholders to discuss how to deliver “Tomorrow’s Normal”—a future of healthcare that is safer, more efficient, and driven by innovation and collaboration. This year’s meeting underscored the importance of strong international partnerships—especially between Japan, the wider Asian market, and the global healthcare community—in shaping the future of medical product development and post-marketing surveillance. The introduction of an English-language track enriched the global exchange of ideas and perspectives.
It was a tremendous experience connecting with the Asian market, yielding remarkable results and forging valuable relationships. We returned inspired, informed, and more committed than ever to advancing global healthcare systems that support vibrant and healthy lives for all.
15-19
JUNE 2025
We are pleased to share that DIA 2025 in Washington, D.C. was a resounding success. Our collaboration with Ascendia Clinical was a key highlight, demonstrating the impact of strategic partnership in advancing the life sciences industry.
Together, we showecased how the integration of GxP compliance and clincial operations expertise can deliver streamlined, end-to-end solutions that meet the evolving needs of clinical research and development.
The event provided a valuable platform to engage with industry leaders, exchange insights, and explore innovative approaches that drive quality and efficiency across the drug development lifecycle.
A sincere thank you to our colleagues, partners, and all who visited our booth and attended our sessions. We look forward to building on this momentum and continuing to support meaningful progress in clinical development.
12-14
MAY 2025
QACV Consulting made its official international debut at the ISPE Europe Annual Conference, showcasing our expertise in global regulatory standards and multilingual auditing capabilities.
Our very first participation in the ISPE Europe Annual Conference was a major milestone for QACV Consulting. This event marked our official international debut, where we proudly highlighted our global reach, multilingual expertise, and deep regulatory knowledge.
It was an honor to connect with industry peers across Europe and demonstrate QACV’s growing presence on the world stage. This first international appearance marked a new chapter in our expansion—and we are just getting started.
06-11
APRIL 2025
QACV Consulting was honored to serve as a Gold Sponsor at the SQA 41st Annual Conference.
As both an exhibitor and featured presenter, QACV Consulting brought forward key discussions on global GxP auditing, regulatory harmonization, sustainability in clinical trials, and inspection readiness strategies.
Our sessions were met with strong engagement and meaningful conversations with colleagues across the industry.
It was a true pleasure to connect with so many SQA members, peers, and clients in person—strengthening partnerships and sharing our passion for quality, compliance, and continuous improvement.
We thank the SQA community for the opportunity to contribute, sponsor, and support this vital annual event. The energy, insights, and collaboration from this conference continue to inspire our global initiatives.
Thank you to everyone who visited and joined our discussions on quality, compliance, and sustainability in global clinical trials.
2024
29-31
july 2024
This conference was the perfect opportunity to show how QACV Consulting can help in this up-and-coming field.
The academic poster was a great addition! It was well received and attracted attention and discussion. One of the conference organizers came to the QACV Consulting booth to let us know that the participants were discussing the QACV Consulting poster presented by Russell Wilson, GMP Lead | Sr. Compliance Consultant. This allowed another path of engagement between QACV Consulting and the attendees.
06-11
april 2024
In April, QACV Consulting successfully participated in the 40th SQA Conference in Aurora, Colorado. The conference provided a valuable opportunity for QACV to engage and interact with outstanding Quality Assurance professionals from around the globe. The seasoned team from QACV Consulting was readily available to discuss QACV’s cutting-edge solutions, specifically designed to meet quality assurance and compliance requirements. QACV Consulting discussions covered a wide range of expertise areas, including Good Clinical Practice (GCP), Good Laboratory Practice (GLP), and various systems, ensuring QACV’s commitment to excellence and innovation in the quality assurance field.
Overall, QACV Consulting’s engagement during the conference significantly reinforced the importance of quality, enhanced safety, regulatory compliance, and, ultimately, greater trust from customers and colleagues by building new and strengthening old relationships. Furthermore, the insights gained from interacting with QA professionals and clients will provide leverage to enhance our services and to better support QACV clients’ needs.
12-15
February 2024
Chris Wubbolt, CEO and Principal, had the privilege of engaging with industry experts, regulatory authorities, and fellow stakeholders in an enriching exchange of insights and best practices.
The February symposium is instrumental in enhancing industries understanding of regulatory expectations and industry trends in GCP and Pharmacovigilance compliance. QACV Consulting is committed to utilizing this knowledge when supporting our clients compliance initiatives.
